Public Policy

What’s Next for Healthcare at Michigan HIMSS Conference?
Public Policy What’s Next for Healthcare at Michigan HIMSS Conference?

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with deep expertise in medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of driving innovation in the industry. Today,

How Do KPDN’s Health Reforms Impact Consumer Rights?
Public Policy How Do KPDN’s Health Reforms Impact Consumer Rights?

Overview of Malaysia’s Healthcare Policy Landscape Imagine a scenario where a visit to a local clinic leaves a patient puzzled over a bill with no breakdown of costs, unsure if the prescribed medication was fairly priced, and feeling lost in a system lacking transparency. This lack of clarity has l

First FDA-Approved ENCELTO Treatment Performed for MacTel
Public Policy First FDA-Approved ENCELTO Treatment Performed for MacTel

Introduction Imagine living with a condition that slowly erases the clarity of central vision, making everyday tasks like reading or recognizing faces increasingly difficult, a reality for individuals diagnosed with idiopathic Macular Telangiectasia Type 2, commonly known as MacTel. This rare

How Will the NHS 10-Year Plan Transform Healthcare Spaces?
Public Policy How Will the NHS 10-Year Plan Transform Healthcare Spaces?

Overview of a Changing Healthcare Landscape Imagine a future where healthcare is no longer confined to the towering walls of hospitals, but instead thrives in accessible, community-centered hubs just a short walk from home. This vision is at the heart of a transformative strategy unveiled by the UK

Vermont Tackles Healthcare Crisis with New Summer Laws
Public Policy Vermont Tackles Healthcare Crisis with New Summer Laws

Vermont stands at a critical juncture in its healthcare system, grappling with a crisis that affects thousands of residents through skyrocketing costs and limited access to essential services, while families in small towns often face the heartbreaking choice between paying for life-saving

Precision Oncology Innovation – Review
Public Policy Precision Oncology Innovation – Review

Imagine a world where a diagnosis of an aggressive, rare cancer like HER2-mutated non-small cell lung cancer (NSCLC) no longer feels like a dead end, especially for the 2% to 4% of NSCLC patients grappling with this subtype. Often marked by poor prognosis and a high risk of brain metastases,

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later